Inactive Instrument

Other languages Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..	Mar. 31
Sawai Group Holdings Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2024	Feb. 13
Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 13
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Nov. 10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024	23-08-09
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for Period Ending September 2023 and Year Ending March 2024	23-08-09
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half Year Ending September 2023 and Fiscal Year Ending March 31, 2024	23-05-11
Sawai Group Holdings Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 28, 2023; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024	23-05-11
Sawai Group Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023	23-02-12
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	23-02-12
Sawai Group Holdings Co., Ltd. Announces Dividend for the Second Quarter Ending September 30, 2022, Payable on December 2, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023	22-11-08
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-11-08
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2023	22-08-10
Sawai Group Holdings Co., Ltd. Provides Earnings Guidance for Period Ending September 2022 and Year Ending March 2023	22-08-10
Japan Index Trades Steadily in Red; Round One Shares Gain 9% as May Sales Exceed Pre-Pandemic Level	22-06-10
Sawai Group Holdings Co., Ltd. Provides Earnings Guidance for Period Ending September 2022 and Year Ending March 2023	22-05-11
Sawai Group Holdings Co., Ltd. Announces Dividend for the Year Ended March 31, 2022, Dividend Payable Date (As Planned) Is June 27, 2022; Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023 and Full Year Ending March 31, 2023	22-05-11
Sawai Pharmaceutical Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2022	22-02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

Other languages

Filters